Alumis Inc. (ALMS) stock
ALMSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.39−0.45 (-9.19%)
Close on Nov 18, 2026Market cap $568.87MP/E –Yield –
Alumis net income
Net income is the profit left for shareholders after every expense, interest and tax.
Alumis's net income for the twelve months ending Jun 30, 2026 was -$438.96M. For fiscal 2025 it was -$243.33M.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$243.33M | – |
| FY2024 | Dec 31, 2024 | -$294.23M | – |
| FY2023 | Dec 31, 2023 | -$154.99M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$142.22M | -339.7% |
| Q1 FY2026 | Mar 31, 2026 | -$93.05M | – |
| Q4 FY2025 | Dec 31, 2025 | -$92.93M | – |
| Q3 FY2025 | Sep 30, 2025 | -$110.75M | – |
| Q2 FY2025 | Jun 30, 2025 | $59.32M | – |
| Q1 FY2025 | Mar 31, 2025 | -$98.96M | – |
| Q4 FY2024 | Dec 31, 2024 | -$94.76M | – |
| Q3 FY2024 | Sep 30, 2024 | -$93.12M | – |
| Q2 FY2024 | Jun 30, 2024 | -$56.51M | – |
| Q1 FY2024 | Mar 31, 2024 | -$49.85M | – |
| Q4 FY2023 | Dec 31, 2023 | -$39.30M | – |
| Q3 FY2023 | Sep 30, 2023 | -$43.38M | – |
| Q2 FY2023 | Jun 30, 2023 | -$36.29M | – |
| Q1 FY2023 | Mar 31, 2023 | -$36.03M | – |
See a number that looks wrong?